tiprankstipranks
Harvard Bioscience (HBIO)
NASDAQ:HBIO
US Market
HBIO
Harvard Bioscience
RESEARCH TOOLSreports

Harvard Bioscience (HBIO) Financial Statements

276 Followers

Harvard Bioscience Financial Overview

Harvard Bioscience's market cap is currently $24.15M. The company's EPS TTM is $0; its P/E ratio is -0.52; Harvard Bioscience is scheduled to report earnings on March 17, 2026, and the estimated EPS forecast is $-6.05. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 86.55M$ 94.14M$ 112.25M$ 113.33M$ 118.90M
Gross Profit$ 45.88M$ 54.77M$ 66.07M$ 60.82M$ 67.65M
Operating Income$ -629.00K$ -6.21M$ 1.89M$ -6.93M$ 2.07M
EBITDA$ 5.32M$ -1.47M$ 8.03M$ 944.00K$ 9.02M
Net Income$ -56.70M$ -12.40M$ -3.42M$ -9.52M$ -288.00K
Balance Sheet
Cash & Short-Term Investments$ 8.61M$ 4.11M$ 4.28M$ 4.51M$ 7.82M
Total Assets$ 80.07M$ 126.64M$ 137.37M$ 145.36M$ 162.34M
Total Debt$ 44.28M$ 44.49M$ 42.77M$ 54.24M$ 56.96M
Net Debt$ 35.66M$ 40.39M$ 38.49M$ 49.73M$ 49.14M
Total Liabilities$ 66.34M$ 63.30M$ 64.29M$ 73.14M$ 78.94M
Stockholders' Equity$ 13.73M$ 63.34M$ 73.07M$ 72.22M$ 83.40M
Cash Flow
Free Cash Flow$ 5.62M$ -1.82M$ 11.72M$ -438.00K$ -83.00K
Operating Cash Flow$ 6.73M$ 1.44M$ 14.03M$ 1.15M$ 1.26M
Investing Cash Flow$ -1.86M$ -1.34M$ -1.80M$ -1.59M$ -1.34M
Financing Cash Flow$ -1.29M$ -131.00K$ -12.13M$ -2.84M$ -252.00K
Currency in USD

Harvard Bioscience Earnings and Revenue History

Income Statement >

Harvard Bioscience Debt to Assets

Balance Sheet >

Harvard Bioscience Cash Flow

Cash Flow >

Harvard Bioscience Forecast EPS vs Actual EPS

Earnings >